Cargando…

Blood neurofilament light chain and thrombospondin-1 levels of patients with autism spectrum disorder

BACKGROUND/AIM: Neurofilaments are intermediary filaments associated with neurodegenerative processes. Thrombospondin-1 (TSP-1) is a biological marker playing a role in synaptogenesis. This study aimed to investigate serum neurofilament light chain (NFL), and TSP1 levels of patients with autism spec...

Descripción completa

Detalles Bibliográficos
Autores principales: PAKETÇİ, Cem, ERMİŞ, Çağatay, ŞİŞMAN, Ali Rıza, HIZ, Semra, BAYKARA, Burak, YİŞ, Uluç
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388028/
https://www.ncbi.nlm.nih.gov/pubmed/36326357
http://dx.doi.org/10.55730/1300-0144.5406
_version_ 1785082018447491072
author PAKETÇİ, Cem
ERMİŞ, Çağatay
ŞİŞMAN, Ali Rıza
HIZ, Semra
BAYKARA, Burak
YİŞ, Uluç
author_facet PAKETÇİ, Cem
ERMİŞ, Çağatay
ŞİŞMAN, Ali Rıza
HIZ, Semra
BAYKARA, Burak
YİŞ, Uluç
author_sort PAKETÇİ, Cem
collection PubMed
description BACKGROUND/AIM: Neurofilaments are intermediary filaments associated with neurodegenerative processes. Thrombospondin-1 (TSP-1) is a biological marker playing a role in synaptogenesis. This study aimed to investigate serum neurofilament light chain (NFL), and TSP1 levels of patients with autism spectrum disorder (ASD) compared to typically developing (TD) children. Materials and methods: Forty-three patients with ASD and forty-five TD children were included. Serum biomarker levels were measured using the sandwich ELISA technique. The Childhood Autism Rating Scale (CARS) was implemented to measure the severity of ASD. RESULTS: NFL and TSP1 levels did not differ between study groups (For NFL, ASD = 47.8 ± 11.4 vs. TD = 48.2 ± 15.3 pg/mL, p = 0.785; for TSP1, ASD = 224.4 ± 53.7 vs. TD = 224.7 ± 69.0 ng/mL, p = 0.828). Stereotyped behavior and sensory sensitivity domain of the CARS scale was negatively correlated with serum TSP-1 (r = −0.390, p = 0.010) and NFL (r = −0.377, p = 0.013) levels. Age was also positively correlated with NFL levels (r = 0.332, p = 0.030) in the ASD groups but not in the TD group. CONCLUSION: Our results did not support the neurodegenerative process of ASD. Future studies are needed to investigate neuroprogression in a longitudinal follow-up.
format Online
Article
Text
id pubmed-10388028
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Scientific and Technological Research Council of Turkey (TUBITAK)
record_format MEDLINE/PubMed
spelling pubmed-103880282023-08-01 Blood neurofilament light chain and thrombospondin-1 levels of patients with autism spectrum disorder PAKETÇİ, Cem ERMİŞ, Çağatay ŞİŞMAN, Ali Rıza HIZ, Semra BAYKARA, Burak YİŞ, Uluç Turk J Med Sci Research Article BACKGROUND/AIM: Neurofilaments are intermediary filaments associated with neurodegenerative processes. Thrombospondin-1 (TSP-1) is a biological marker playing a role in synaptogenesis. This study aimed to investigate serum neurofilament light chain (NFL), and TSP1 levels of patients with autism spectrum disorder (ASD) compared to typically developing (TD) children. Materials and methods: Forty-three patients with ASD and forty-five TD children were included. Serum biomarker levels were measured using the sandwich ELISA technique. The Childhood Autism Rating Scale (CARS) was implemented to measure the severity of ASD. RESULTS: NFL and TSP1 levels did not differ between study groups (For NFL, ASD = 47.8 ± 11.4 vs. TD = 48.2 ± 15.3 pg/mL, p = 0.785; for TSP1, ASD = 224.4 ± 53.7 vs. TD = 224.7 ± 69.0 ng/mL, p = 0.828). Stereotyped behavior and sensory sensitivity domain of the CARS scale was negatively correlated with serum TSP-1 (r = −0.390, p = 0.010) and NFL (r = −0.377, p = 0.013) levels. Age was also positively correlated with NFL levels (r = 0.332, p = 0.030) in the ASD groups but not in the TD group. CONCLUSION: Our results did not support the neurodegenerative process of ASD. Future studies are needed to investigate neuroprogression in a longitudinal follow-up. Scientific and Technological Research Council of Turkey (TUBITAK) 2022-05-07 /pmc/articles/PMC10388028/ /pubmed/36326357 http://dx.doi.org/10.55730/1300-0144.5406 Text en © TÜBİTAK https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Research Article
PAKETÇİ, Cem
ERMİŞ, Çağatay
ŞİŞMAN, Ali Rıza
HIZ, Semra
BAYKARA, Burak
YİŞ, Uluç
Blood neurofilament light chain and thrombospondin-1 levels of patients with autism spectrum disorder
title Blood neurofilament light chain and thrombospondin-1 levels of patients with autism spectrum disorder
title_full Blood neurofilament light chain and thrombospondin-1 levels of patients with autism spectrum disorder
title_fullStr Blood neurofilament light chain and thrombospondin-1 levels of patients with autism spectrum disorder
title_full_unstemmed Blood neurofilament light chain and thrombospondin-1 levels of patients with autism spectrum disorder
title_short Blood neurofilament light chain and thrombospondin-1 levels of patients with autism spectrum disorder
title_sort blood neurofilament light chain and thrombospondin-1 levels of patients with autism spectrum disorder
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388028/
https://www.ncbi.nlm.nih.gov/pubmed/36326357
http://dx.doi.org/10.55730/1300-0144.5406
work_keys_str_mv AT paketcicem bloodneurofilamentlightchainandthrombospondin1levelsofpatientswithautismspectrumdisorder
AT ermiscagatay bloodneurofilamentlightchainandthrombospondin1levelsofpatientswithautismspectrumdisorder
AT sismanalirıza bloodneurofilamentlightchainandthrombospondin1levelsofpatientswithautismspectrumdisorder
AT hizsemra bloodneurofilamentlightchainandthrombospondin1levelsofpatientswithautismspectrumdisorder
AT baykaraburak bloodneurofilamentlightchainandthrombospondin1levelsofpatientswithautismspectrumdisorder
AT yisuluc bloodneurofilamentlightchainandthrombospondin1levelsofpatientswithautismspectrumdisorder